IIIM Jammu conducts 3-4 clinical trials of Kovid-19 drug formulations: Director

Must Read

As Sanjay Dutt fights cancer, wife Manayata describes how they are alive given what she has to bear: ‘You walk together’ – Bollywood

Actor Sanjay Dutt's wife Manayata has shared a new picture of the two, along with Sanjay's words of empowerment...

Priyanka Chopra joined Idris Elba, Salma Hayek for the first time to narrate diverse stories through filmmakers – Bollywood

Priyanka Chopra's production house Purple Pebble Pictures, which she runs with her mother Madhu Chopra, has now partnered with...

Man follows Abhishek Bachchan more than Prachi Desai, the actor’s brilliant answer is – Bollywood

Actor Abhishek Bachchan has responded to a Twitter user who suggested that the actor is popular due to the...

Let’s Start this Interesting Article Shared on DesiNew.xyz

Jammu: The Indian Institute of Integrative Medicine (IIIM) is conducting clinical trials of 3-4 formulations to develop the Kovid-19 drug, a senior official had said.

IIIM is in the final stages of validating a new machine-less coronavirus diagnostics kit, as already reported by PTI, which could help the country scale up the Kovid-19 test.

“For Kovid-19, we are undergoing clinical trials. In collaboration with the Ministry of AYUSH and the industry, we are involved in this. Three to four clinical trials in relation to Kovid-19 drugs form 3 to 4. In relation to various plant species. Dr. CS Srinivas Reddy, Director CSIR-Indian Institute of Integrative Medicine (IIIM), told PTI.

“If they (all the necessary tests) are successful, we can make the medicine available soon”, Reddy said.

“We are definitely getting closer. Many research groups around the world are giving their best to find a treatment for Kovid-19. The discovery of new drugs is a very long and expensive process”, he said.

The director said that reuse of drugs already known to treat Kovid-19 patients is the best option under current circumstances.

He said, “Many academic and industry groups around the world are continuously working. In India, CSIR (Council of Scientific and Industrial Research) in particular is at the forefront.”

Dr. Reddy, who recently took over as director of IIIM for the next six years, said the first activity that IIIM carried out under him was testing Kovid-19 samples.

“We started the trial in the first week of April in collaboration with the Government Medical College (GMC), Jammu. We have completed more than 40,000 samples so far,” he said.

“We are in the process of increasing the number of samples tested,” he said.

He said that IIIM is in the process of developing a new formulation based on zinc gluconate and natural vitamin C, which comes from Acerola Cherry to enhance immunity.

“It is in cooperation with a company.”

He said that development processes for active drug ingredients (APIs) as part of the reproduction of drugs are underway and that “our scientists have made significant progress on this activity and demonstrated one of the processes to an industry partner in Jammu has gone”.

He said, “We continue to work along these lines and start some new initiatives to solve Kovid-19 related problems. Our scientists and students rose to the occasion and made significant contributions in a short period of time.”

Dr. Reddy said the IIIM laboratory is a unique location for drug discovery based on natural products – all under one roof for plant-based or new chemical unit (NCE) -based drugs.

“The region has a rich biodiversity known for medicinal and aromatic plants. It has a diverse scientific pool with expertise and experience from various functions. I get a lot of opportunities here,” he said. .

He said that IIIM could lead programs of national importance besides existing assets and expand the campus or natural product extracts library and open it up for other research purposes.

He said that IIIM can develop agricultural technologies and commercial farming in the western Himalayan Kashmir Valley and Ladakh regions.

“There are high value medicinal and aromatic plants, (but) they are facing problems in the supply chain, in particular, for international markets. IIIM can put more efforts in that direction ”, he said.

STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

As Sanjay Dutt fights cancer, wife Manayata describes how they are alive given what she has to bear: ‘You walk together’ – Bollywood

Actor Sanjay Dutt's wife Manayata has shared a new picture of the two, along with Sanjay's words of empowerment...

Priyanka Chopra joined Idris Elba, Salma Hayek for the first time to narrate diverse stories through filmmakers – Bollywood

Priyanka Chopra's production house Purple Pebble Pictures, which she runs with her mother Madhu Chopra, has now partnered with ViacomCBS Entertainment and Youth Group,...

Man follows Abhishek Bachchan more than Prachi Desai, the actor’s brilliant answer is – Bollywood

Actor Abhishek Bachchan has responded to a Twitter user who suggested that the actor is popular due to the family he belongs to as...

‘This has brought tears to my eyes’: Kangana Ranaut ransacked her house after Bombay HC commented – Bollywood

Kangana Ranaut said that she got emotional after hearing her petition on behalf of the Mumbai High Court against the demolition of a part...

International Imies: Delhi Crime, Four More Shots Please, Arjun Mathur files nomination for India – TV

Four more shots of the Netflix series Delhi Crime, Amazon Prime Please and actor Arjun Mathur have been nominated internationally. Nominations were announced on...
- Advertisement -

More Articles Like This

- Advertisement -